AU4115100A - Pharmaceutical composition on the basis of erythromycin fatty acid salts for thetopical treatment of skin diseases - Google Patents

Pharmaceutical composition on the basis of erythromycin fatty acid salts for thetopical treatment of skin diseases

Info

Publication number
AU4115100A
AU4115100A AU41151/00A AU4115100A AU4115100A AU 4115100 A AU4115100 A AU 4115100A AU 41151/00 A AU41151/00 A AU 41151/00A AU 4115100 A AU4115100 A AU 4115100A AU 4115100 A AU4115100 A AU 4115100A
Authority
AU
Australia
Prior art keywords
thetopical
basis
treatment
pharmaceutical composition
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41151/00A
Other languages
English (en)
Inventor
Ulrich Knie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr August Wolff GmbH and Co KG Arzneimittel
Original Assignee
Dr August Wolff GmbH and Co KG Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr August Wolff GmbH and Co KG Arzneimittel filed Critical Dr August Wolff GmbH and Co KG Arzneimittel
Publication of AU4115100A publication Critical patent/AU4115100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU41151/00A 1999-04-19 2000-04-03 Pharmaceutical composition on the basis of erythromycin fatty acid salts for thetopical treatment of skin diseases Abandoned AU4115100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19917548 1999-04-19
DE19917548A DE19917548A1 (de) 1999-04-19 1999-04-19 Pharmazeutische Zusammensetzung auf der Basis von Erythromycin-Fettsäuresalzen mit 12 bis 22 Kohlenstoffatomen im Fettsäurerest und Verwendung dieser Erythromycin-Fettsäuresalze zur topischen Behandlung von Hauterkrankungen
PCT/EP2000/002950 WO2000062784A1 (de) 1999-04-19 2000-04-03 Pharmazeutische zusammensetzung auf der basis von erythromycin-fettsäuresalzen zur topischen behandlung von hauterkrankungen

Publications (1)

Publication Number Publication Date
AU4115100A true AU4115100A (en) 2000-11-02

Family

ID=7905021

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41151/00A Abandoned AU4115100A (en) 1999-04-19 2000-04-03 Pharmaceutical composition on the basis of erythromycin fatty acid salts for thetopical treatment of skin diseases

Country Status (11)

Country Link
EP (1) EP1085883A1 (sk)
AU (1) AU4115100A (sk)
BG (1) BG105093A (sk)
DE (1) DE19917548A1 (sk)
EE (1) EE200000727A (sk)
HR (1) HRP20000884A2 (sk)
HU (1) HUP0102702A3 (sk)
NO (1) NO20006260L (sk)
PL (1) PL344988A1 (sk)
SK (1) SK18652000A3 (sk)
WO (1) WO2000062784A1 (sk)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114632139B (zh) * 2022-04-02 2023-04-07 北京双吉制药有限公司 一种红霉素药膏及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2383667A1 (fr) * 1977-03-16 1978-10-13 Desjonqueres Stephane Medicament contre l'acne
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
IT1210608B (it) * 1980-12-08 1989-09-14 Rorer Int Overseas Composizione per il trattamento topico dell'acne
DE3375376D1 (en) * 1982-10-15 1988-02-25 Procter & Gamble Storage stable topical pharmaceutical composition including nitrogen-containing stabilizers
JPS6021831A (ja) * 1983-07-11 1985-02-04 コ−ニング・グラス・ワ−クス 陰極線管のフエ−スプレ−ト用ガラス
LU86945A1 (fr) * 1987-07-17 1989-03-08 Oreal Compositions pharmaceutiques et cosmetiques a base de pyridones et d'agents antibacteriens
DE19706979A1 (de) * 1997-02-21 1998-08-27 Lindopharm Gmbh Kombinationspräparat für oral applizierbare Erythromycine

Also Published As

Publication number Publication date
HUP0102702A3 (en) 2003-02-28
HRP20000884A2 (en) 2001-10-31
PL344988A1 (en) 2001-11-19
HUP0102702A2 (hu) 2001-12-28
SK18652000A3 (sk) 2001-08-06
BG105093A (bg) 2001-07-31
WO2000062784A1 (de) 2000-10-26
NO20006260L (no) 2001-02-19
NO20006260D0 (no) 2000-12-08
EE200000727A (et) 2002-04-15
DE19917548A1 (de) 2000-10-26
EP1085883A1 (de) 2001-03-28

Similar Documents

Publication Publication Date Title
HK1037861A1 (en) Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention
AU3469400A (en) Pharmaceutical compositions for treatment of diseased tissues
AU1773600A (en) Topical treatment of skin disease
HUP0104963A3 (en) Compositions for the treatment of skin diseases
AUPQ474599A0 (en) Endoscope for surgical treatment of haemorrhoids
AU2002368219A1 (en) Dermatological preparation for the treatment of skin lesions
AU6092900A (en) Animals comprising human hepatocellular tissue
AU1878201A (en) Composition for the treatment of damaged tissue
AU4937699A (en) Use of succinic acid or salts thereof for the treatment of diabetes mellitus andwound healing
AU4115100A (en) Pharmaceutical composition on the basis of erythromycin fatty acid salts for thetopical treatment of skin diseases
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU2900100A (en) Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss
AU2509801A (en) Method for the cosmetic treatment of human skin
AU6439400A (en) Skin cosmetic compositions for reducing skin irritation from weak carboxylic acids
AU1405001A (en) Treatment of diseases
IL150122A0 (en) Remedies for external use for allergic skin diseases
AU2683500A (en) Compositions for the treatment of pain
AU2001282410A1 (en) N-benzylindole-3-acetic acid derivatives for use in the treatment of drug resistan cancer
AU5416500A (en) Pharmaceutical composition for the treatment of calcification
AU4101900A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
AUPQ902000A0 (en) Pharmaceutical composition for the treatment of skin conditions
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases
AU7599700A (en) Use of anti-inflammatory drugs for treatment of dermatological conditions
AU1002697A (en) Topical compositions for the treatment of skin disease
PL350327A1 (en) Compositions for the treatment of skin diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase